Quest Diagnostics (DGX) Change in Cash (2009 - 2026)

Quest Diagnostics has disclosed Change in Cash across 18 years of filings, most recently posting -$27.0 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$27.0 million, up 92.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $205.0 million (up 171.68% YoY), and the FY2025 annual result was -$129.0 million, up 5.84% from the prior year.
• Change in Cash came in at -$27.0 million for Q1 2026 at Quest Diagnostics, down from -$12.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $543.0 million in Q4 2023 to a low of -$385.0 million in Q4 2022.
• The 5-year median for Change in Cash is -$49.0 million (2023), against an average of -$28.2 million.
• Across the five-year window, Change in Cash tumbled 322.22% in 2022 and jumped 2800.0% in 2024, its largest moves.
• Quest Diagnostics' Change in Cash stood at -$385.0 million in 2022, then surged by 241.04% to $543.0 million in 2023, then tumbled by 139.59% to -$215.0 million in 2024, then jumped by 94.42% to -$12.0 million in 2025, then tumbled by 125.0% to -$27.0 million in 2026.
• The last three Change in Cash figures came in at -$27.0 million (Q1 2026), -$12.0 million (Q4 2025), and $113.0 million (Q3 2025), per Business Quant data.